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Abstract
 Objective—To describe the clinical presentation and outcomes of Acanthamoeba keratitis 
(AK) in rigid gas permeable (RGP) contact lens wearers and identify modifiable risk factors.
 Design—A case-control investigation.
 Participants—Case-patients were RGP contact lens-wearing U.S. residents with a diagnosis 
of AK during 2005–2011. Controls were RGP contact lens wearers with no history of AK and at 
least 12 years of age.
 Methods—Case-patients were identified during two multi-state AK outbreak investigations. 
Controls from the first investigation in 2007 were identified using a reverse address directory. In 
the second investigation, controls were recruited from participating ophthalmology and optometry 
practices. Case-patients and controls were interviewed by phone using a standardized 
questionnaire. Odds ratios (ORs) and Fisher’s exact P-values were calculated to assess risk factors 
associated with infection.
 Main Outcome Measures—AK, a rare eye disease primarily affecting contact lens wearers, 
is caused by free-living amebae, Acanthamoeba spp.
 Results—We identified 37 case-patients in the two investigations, 10 (27%) from the 2007 
investigation and 27 (73%) from 2011. There were 17 healthy controls, 9 (53%) from 2007 and 8 
(47%) from 2011. Among case-patients, 9 (24%) wore RGP lenses for orthokeratology or 
therapeutic indication; no controls wore RGP lenses for these indications. Significant risk factors 
for AK were wearing lenses for orthokeratology (OR undefined, P=0.02), sleeping while wearing 
lenses (OR 8.00, P=0.04), storing lenses in tap water (OR 16.00, P=0.001), and topping off contact 
lens solution in the case (OR 4.80, P=0.01). After stratifying by use of RGP lenses for 
orthokeratology, storing lenses in tap water and topping off remained significant exposures.
 Conclusions—Nearly a quarter of case-patients were orthokeratology wearers. Using tap 
water to store RGP lenses and topping off solution in the lens case were modifiable risk behaviors 
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identified in RGP wearers who wore lenses for both orthokeratology and non-orthokeratology 
indications. RGP wearers should avoid exposing their lenses to tap water and should empty their 
cases and use fresh lens solution each time they take out their lenses.
Acanthamoeba keratitis (AK) is a severe infection of the eye with significant risk of vision 
loss due to corneal ulceration and scarring. Acanthamoeba species are free-living amebae 
ubiquitous in the environment and found in water and soil. Wearing soft contact lenses 
(SCL) is a well-documented risk factor for Acanthamoeba eye infection1; however, AK 
reports in patients who wear rigid contact lenses, such as rigid gas permeable (RGP) contact 
lenses , are limited and risk factors for developing AK among RGP wearers have not been 
previously described.
In the United States, RGP lenses are used by a small proportion of contact lens wearers for 
the correction of simple refractive error. The most recent estimates suggest that RGP lenses 
comprise approximately 6.5% of the 40.9 million contact lens wearers in the United States.2 
Soft contact lenses are much more comfortable, especially on initial fitting, and are available 
in a wide range of powers accommodating mild to moderate amounts of astigmatism. RGP 
lenses are often used in the setting of high astigmatism, irregular astigmatism and for 
orthokeratology (the practice of using RGP lenses to temporarily reshape the cornea to 
reduce refractive errors).
Among soft contact lens wearers, case-control studies have shown several behaviors to be 
risk factors for AK. These include use of homemade saline, suboptimal disinfection of 
lenses, and “topping off” (adding new solution to an existing volume of used solution in the 
lens case ).1, 3, 4 Reported cases of Acanthamoeba infection in RGP wearers have been few, 
primarily in orthokeratology patient case reports and case series.5-9 However, to our 
knowledge, no controlled studies assessing risk factors for AK among RGP wearers have 
been published.
In 2007 and 2011, the U.S. Centers for Disease Control and Prevention (CDC) conducted 
multi-state investigations of nationwide AK outbreaks. From these investigations, we present 
the largest case series to date of AK in rigid lens wearers, a description of clinical outcomes, 
and analyses of risk factors for infection using healthy RGP wearer controls.
 METHODS
Case-patients and controls for this analysis were identified during two multi-state outbreak 
investigations conducted by CDC in 2007 and 2011. The goal of these investigations was to 
determine clinical characteristics, risk factors, diagnostic modalities and outcomes of AK 
cases. Methods for the 2007 investigation have been described previously.4 Briefly, case-
patients with confirmed AK (defined as AK with onset of symptoms on or after January 1, 
2005; diagnosed by an ophthalmologist; and confirmed by cultures of corneal specimens) 
were solicited from ophthalmologists, laboratories, and public health officials nationwide. 
Controls were recruited via random-digit dialing and were restricted to persons who had no 
history of AK.
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For the 2011 investigation, case-patients with confirmed AK (defined as AK with onset of 
symptoms between January 1st, 2008 and June 12th, 2011; diagnosed by an 
ophthalmologist; and confirmed by culture, histology or confocal microscopy) were 
identified from a sentinel network of 15 reference laboratories and ophthalmologic 
institutions formed in response to the 2007 investigation or new collaborations with 
additional institutions.10 Because control recruitment via random-digit dialing had been 
resource-intensive in the 2007 investigation, controls were recruited from patients of 
optometrists and ophthalmologists located in the same states of residence as case patients. 
Controls wore contact lenses and had no history of AK.
Both investigations were conducted as part of an urgent public health response and as such, 
were deemed non-research by the Human Research Protection Coordinator and not subject 
to Institutional Review Board approval. Both cases and controls provided informed consent 
to be interviewed. Excepting basic demographic and clinical characteristics, the data derived 
from RGP case-patient and control interviews used in this study have not been published 
previously.
For both outbreak investigations, case-patients and controls were interviewed by phone with 
a standardized questionnaire that assessed contact lens use, contact lens care behaviors and 
risk factors, and demographics. To gather more information about their illness, case-patients 
were also asked about their symptoms. In addition, standardized chart abstraction forms 
were sent to the case-patients’ ophthalmologists in order to collect information on presenting 
signs and symptoms, disease progression, diagnosis, treatment and outcome.
This analysis was restricted to case-patients and controls who reported wearing RGP lenses. 
Data from phone interviews and chart abstraction forms were analyzed using SAS 9.3 © 
(SAS Institute Inc., Cary, NC, USA). Odds ratios (ORs) and p-values were calculated to 
assess exposures associated with case-control status. Because of the small numbers in this 
analysis, exact p-values were calculated using Fisher’s exact test in place of confidence 
intervals. Results were considered statistically significant at P<0.05. Additionally, because 
of the small numbers in this analysis, multivariable logistic regression was not conducted. 
Instead, to examine differences in exposures between orthokeratology patients and non-
orthokeratology patients, stratified analyses were conducted.
 RESULTS
We identified 37 case-patients in the two investigations, 10 (27%) from the 2007 
investigation and 27 (73%) from 2011. There were 17 healthy RGP-wearing controls, 9 
(53%) from 2007 and 8 (47%) from 2011. The most frequently reported symptoms among 
case-patients were redness, sensitivity to light, and increased tearing (Table 1). The median 
time from onset of symptoms to initiation of anti-ameba treatment was 40 days (range 13–
1154 days). At the time of data collection, 10 (30.3%) of 33 case-patients with known 
outcome had undergone keratoplasty after failing anti-ameba therapy and 18 (56.3%) of 32 
had a visual acuity of 20/200 or worse with best correction (i.e. legally blind) in the affected 
eye.
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Demographic features of the cases and controls are summarized in Table 2. Among the 37 
RGP wearers with AK, a minority (10 cases, 27%) were male and most (23 cases, 62%) 
were over 55 years of age. Among controls, 1 respondent (6%) was male and half (8 
controls, 50%) were over 55 years of age. Among cases, 9 (24%) wore RGP lenses for 
orthokeratology (8 cases) or therapeutic indication (1 case); no controls wore RGP lenses for 
these indications. Most cases (81%) and all controls (100%) had worn contact lenses for 
more than 10 years.
Table 2 shows the prevalence and unadjusted odds ratios for exposures. In univariable 
analyses, cases had higher odds of being 25 years of age or less (vs. being 26-55 years of 
age) when compared with controls (OR undefined, P=0.04). Cases were more likely to wear 
lenses for orthokeratology or therapeutic indication (OR undefined, P=0.02), wear lenses for 
less than 12 hours per day (OR 3.66, P=0.04), or sleep in their contact lenses (OR 8.00, 
P=0.04) in comparison with controls.
Cases had elevated odds of having municipal water as their tap water source (vs. a private 
well) compared with controls (P=0.02). Cases also had significantly higher odds of ever 
storing their lenses in tap water (OR 16.00, P=0.001) and of topping off solution (OR 4.80, 
P=0.01). Forty-five percent of case-patients who used municipal water reported storing their 
lenses in water compared with 10% of controls. Among users of private well water, 66.7% 
of case-patients reported storing their lenses in water compared with none of the controls.
To examine differences in exposures between orthokeratology wearers and others, we 
stratified results by use of rigid lenses for orthokeratology or therapeutic use. Among rigid 
lens wearers who did not wear lenses for orthokeratology or therapeutic indication (wore for 
vision correction only), being age ≤ 25 years, reporting duration of wear < 12 hours per day, 
and wearing lenses overnight were no longer significantly associated with case status, 
despite remaining elevated (Table 3). Because no controls were orthokeratology patients, we 
were unable to further compare exposures among RGP wearers who were orthokeratology 
patients.
 DISCUSSION
This analysis of the largest case series of AK in RGP contact lens wearers in the United 
States identified important characteristics of clinical presentation and outcomes, along with 
significant differences in exposures between case-patients and controls. Case-patients had 
elevated odds of two potentially modifiable behaviors, storing lenses in tap water and 
topping off lens solution in the case. A notable finding of this study was that nearly a quarter 
of AK case-patients were orthokeratology wearers.
Cases and case series of AK among orthokeratology wearers have been reported in the 
literature previously.6-9, 11 However, to our knowledge, this analysis is the first to examine 
exposure to orthokeratology in a case-control study of AK. The only other study to date that 
has looked at orthokeratology as a risk factor for microbial keratitis used a retrospective 
cohort design and found that the risk of microbial keratitis in orthokeratology wearers was 
similar to other overnight modalities.12 No cases of AK were reported in that study.
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Although a quarter of AK case-patients in this analysis were orthokeratology wearers, no 
controls were, and an odds ratio assessing the risk of wearing RGP lenses for 
orthokeratology in AK case-patients could not be calculated. However, a recent survey of 
contact lens prescribing trends in the United States found that an average of 4.5% of rigid 
lens fits were for orthokeratology.13 If 4.5% of the controls in this analysis had been 
orthokeratology wearers, case-patients would have 6.8 times the odds of being an 
orthokeratology wearer when compared with controls.
Orthokeratology wearers could be at greater risk of developing AK. However, 
orthokeratology wearers as a group differ from other RGP wearers in several ways and 
potential for confounding exists. Orthokeratology wearers tend to be younger on average, 
and younger age has been associated with poorer contact lens hygiene.14 Sleeping in contact 
lenses, which is usually how orthokeratology lenses are prescribed, is a known risk factor for 
microbial keratitis, but has not been a consistent risk factor for either amebic or fungal 
keratitis among soft contact lens wearers.15-18 However, sleeping in contact lenses when tear 
production is physiologically decreased, regardless of the material, potentiates changes in 
the cornea that can result in corneal epithelial microtrauma that puts the contact lens wearer 
at higher risk for keratitis.19 Additionally, orthokeratology lenses are fit with a different lens/
cornea relationship than non-orthokeratology lenses.20 This fit leads to a greater bearing on 
the central cornea which may compromise the corneal epithelial barrier and exposes the 
cornea to several hours of hypoxia leading to a higher risk of infections.21 Other therapeutic 
indications that mold the corneal surface might also increase the risk of corneal 
microtrauma. As a result, contact lens wearers of any type should consider minimizing 
contact lens wear while sleeping. For those patients in whom overnight wear for 
orthokeratology is considered, strict adherence to good contact lens hygiene practices and 
avoidance of tap water for storage (no FDA-approved care regimen recommends tap water 
storage) should be highly recommended in order to minimize risk of AK or other types of 
microbial keratitis. Furthermore, the appearance of keratitis in an individual using contact 
lenses for orthokeratology should trigger concern for the possibility of AK.
Younger age, wearing lenses for less than 12 hours per day, and overnight contact lens wear 
were found to be significant risk factors in the overall analysis. Based on characteristics of 
typical orthokeratology patients (younger patients, wearing lenses overnight for <12 hours), 
we hypothesized that these risk factors were actually markers for orthokeratology. When 
analyses were restricted to non-orthokeratology wearers, odds of age <25 years, duration of 
wear <12 hours per day, and overnight lens wear were still elevated but no longer 
statistically significant in case-patients. Younger age may be associated with poorer contact 
lens hygiene and overnight contact lens wear has been previously associated with microbial 
keratitis.14, 16 Wearing lenses <12 hours per day has not been previously reported as a risk 
factor, to our knowledge, but could perhaps be associated with longer time in the lens case 
(i.e., prolonged exposure to a potentially contaminated lens case) or be a marker for uses of 
lenses for orthokeratology (i.e. wearing only while sleeping overnight which would typically 
amount to <12 hours of wear).
Case-patients were 16 times more likely than controls to store their lenses in tap water. This 
modifiable risk factor for AK has been reported previously and has clear biologic 
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plausibility.22-25 Acanthamoeba is a hardy, chlorine-resistant organism that thrives in the 
nutrient-poor setting of drinking water distribution systems and premise plumbing.26 
Acanthamoeba is a frequent inhabitant of biofilms in pipes and was found in 51% of 
households in an Ohio study, 9.3% of household samples in West Virginia and 13% of 
drinking water distribution systems in Virginia.27-30 Thus, recommendations to contact lens 
wearers to avoid tap water exposure are a refrain that echoes back to some of the first 
investigations of Acanthamoeba keratitis in contact lens wearers in the 1980’s.3 That 50% of 
case-patients in this analysis reported storing their lenses in tap water is perhaps an 
indication of the need for continued reiteration of this recommendation.
Although rinsing lenses with tap water was not significantly associated with case status in 
this analysis, case-patients were twice as likely than controls to rinse their lenses in tap water 
(OR 2.04, p=0.1984). While lens storage in tap water likely represents a much more 
prolonged, intense exposure to Acanthamoeba compared with rinsing lenses in tap water, the 
small number of participants in this analysis mean that an elevated risk for Acanthamoeba 
keratitis among contact lens wearers who rinse their lenses with tap water cannot be ruled 
out.
Some RGP cleaning systems continue to recommend the use of tap water for the rinsing 
step.31 Based on instructions that state to rinse with tap water, RGP wearers might assume 
that storage in tap water is acceptable as well. To avoid mixed public health messaging, it 
might be preferable to advise RGP wearers to avoid tap water in all steps of the cleaning 
process and storage of their lenses. The use of commercial saline as a rinse may be a 
reasonable alternative to tap water.
While the association of AK and contact with tap water is clear, the association between the 
type of water source and AK is less so. Case-patients were more likely to have municipal 
water (vs. a private well) than controls. Among case-patients, 8.6% of respondents identified 
a private well as their drinking water source, while 37.5% of controls had well water. The 
prevalence of well water use among the 17 controls in this study is higher than that found in 
the general U.S. population (approximately 12% of households are supplied by a private 
well).32 Acanthamoeba spp. are a common microbial inhabitant of water sources, including 
wells and groundwater sources28, 33, 34 and studies have shown an increased risk for AK 
associated with showering, using hot tubs, and swimming with contact lenses.35, 36 Other 
studies have shown associations with AK and water quality, case-patient geography, and 
water storage practices.22, 36, 37 The role of biofilm formation in water systems, methods of 
water treatment, and their contribution to the presence of Acanthamoeba in tap water is still 
not clear and requires further study.
Case-patients were more likely to report topping off. This modifiable risk factor has been 
previously identified in soft contact lens wearers in two multistate outbreaks of microbial 
keratitis, one involving Acanthamoeba and the other, Fusarium.4, 38 Contact lens solution in 
the lens case can become contaminated (e.g., by organisms on contact lenses or transferred 
via fingers when placing lenses in the case). Topping off may also promote the formation of 
biofilm, which is a food source for Acanthamoeba.39 As the solution is exposed to more 
organic material, the disinfectant is consumed, leaving less disinfectant available to 
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inactivate pathogens.40-42 Subsequently, when a fraction of new disinfectant is added to the 
old, inactive solution (“topping off”), the active disinfectant concentration is diluted 
significantly, allowing pathogens to proliferate on the lens and in the case. Therefore, rigid 
lens wearers should avoid topping off the disinfecting solution in the lens storage case.
RGP wearers with AK had similar presenting symptoms to soft contact lens wearers with 
AK identified in the 2007 outbreak investigation.4 While the median time from onset of 
symptoms to initiation of anti-ameba therapy was no longer in RGP case-patients compared 
with soft contact lens wearers in the 2007 investigation (40 days vs. 49 days)4, some RGP 
case-patients did not receive treatment until over a year after symptom onset, potentially 
leading to worse outcomes. A similar proportion of RGP wearers required keratoplasty (30% 
vs 29%) but a higher proportion had a best corrected visual acuity of 20/≥200 in the affected 
eye (56% vs. 41%) compared with soft contact lens wearers from the 2007 investigation.4 
The diagnosis of AK should be considered early in a patient with keratitis to ensure the best 
chance for full recovery.
The findings of this analysis are subject to several limitations, including both those present 
in the larger case-control investigations from which these case-patients and controls were 
derived as well as those inherent to this particular analysis. Limitations of the larger 2007 
and 2011 investigations included recall bias related to participants’ limited recollection of 
behaviors during the 2 years before the investigations. Additionally, selection bias might 
have been present among controls given the low response rate among controls and the use of 
ophthalmology and optometry office-based controls. In this particular analysis, our findings 
are limited by the small sample size of RGP wearers, likely reducing the statistical power to 
detect smaller differences among the case-patients and controls as well as prohibiting the use 
of a multivariable model to control for confounding. Furthermore, we were not able to assess 
age of RGP lenses as a risk factor for AK as this data was not collected during the multi-
state investigations. In spite of these limitations, this case-control study of AK in RGP 
wearers fills a gap in the contact lens literature.
Overall, our findings indicate that modifiable risk factors for AK among RGP wearers who 
wear lenses for vision correction are similar to those for soft contact lens wearers, namely 
avoiding exposure to tap water and practicing good contact lens wear and care habits. 
Therefore, prevention messages should be broadly applicable to all contact lens wearers. 
Public health messaging that encompasses risk factors for both rigid and soft contact lenses 
and for bacterial, fungal and amebic infections is likely to be the most effective. The most 
important of these messages include minimizing overnight wear, reducing exposure of lenses 
to tap water, not topping off contact lens solutions, and frequent replacement of the contact 
lens case. Providers should also carefully evaluate candidates for orthokeratology to ensure 
they can comply with hygiene recommendations. For more information on healthy contact 
lens wear and care, visit http://www.cdc.gov/contactlenses.
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Table 1
Clinical characteristics and outcomes of Acanthamoeba keratitis infection among rigid 
gas-permeable lens wearers — United States, 2005–2011
Eye Affected (n=37)
Left eye affected 21 (56.8)




Sensitivity to light 27 (73.0)
Increased tearing 25 (67.6)
Foreign body sensation 24 (64.9)
Eye pain 24 (65.9)
Blurred vision 17 (45.9)
Eye discharge 10 (27.0)
Outcome (n=33)
Resolved 13 (39.4)
Still on anti-ameba therapy, no keratoplasty performed 9 (27.3)
Keratoplasty after failed therapy 10 (30.3)
Transplant planned 1 (3.0)
Best corrected visual acuity in the affected eye (n=32)
20/20 3 (9.4)
20/25 – 20/50 7 (21.9)
20/60 – 20/100 4 (12.5)
20/200 – 20/400 12 (37.5)
20/800 – 20/1200 5 (15.6)
Light perception 0 (0)
No light perception or enucleated 1 (3.1)
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Table 2
Prevalence and odds ratio of demographic characteristics and potential risk factors for 
infection in Acanthamoeba keratitis cases and controls who wore rigid gas-permeable 
lenses — United States, 2005 – 2011
Cases (N=37) Controls (N=17)
Demographic characteristic or
exposure
n (%) n (%) Unadjusted odds
ratio (p-value)*
Age
25 years or younger 6/36 (16.2) 0 undefined (p=0.04)**
26–55 years 8/36 (21.6) 8/16 (50.0) referent
56 years or older 23/36 (62.2) 8/16 (50.0) 2.88 (p=0.09)
Male 10/37 (27.0) 1/16 (6.3) 5.42 (p=0.08)
Non-Hispanic ethnicity 34/36 (94.4) 14/16 (87.5) 2.42 (p=0.36)
Non-white race 4/35 (11.4) 1/16 (6.3) 1.94 (p=0.49)





3/37 (8.1) 1/17 (5.9) 1.41 (p=0.63)
Indications for RGP use
Vision correction 28/37 (75.7) 17/17 (100) referent
Orthokeratology/therapeutic
† 9/37 (24.3) 0 (0) undefined (p=0.02)**
Length of prior contact lens wear
 <1 year 2/37 (5.4) 0 (0) undefined (p=0.42)
 1-5 years 4/37 (10.8) 0 (0) undefined (p=0.19)
 6-10 years 1/37 (2.7) 0 (0) undefined (p=0.65)
 >10 years 30/37 (81.1) 17/17 (100) referent
Duration of daily lens wear
<12 hrs./day 18/37 (48.7) 4/17 (23.5) 3.66 (p=0.04)**
>12-16 hrs./day 16/37 (43.2) 13/17 (76.5) referent
>16 hrs./day 3/37 (8.1) 0 (0) undefined (p=0.20)
Overnight contact wear
Never slept with lenses in 24/36 (66.7) 16/17 (94.1) referent
Slept with lenses in some nights
†† 6/36 (16.7) 1/17 (5.9) 4.00 (p=0.19)
Slept with lenses in every night
†† 6/36 (16.7) 0 (0) undefined (p=0.06)
Any sleeping with lenses in
†† 12/36 (33.3) 1/17 (5.9) 8.00 (p=0.04)**
Smoking
Ever smoked 16/36 (44.4) 5/17 (29.4) 1.92 (p=0.23)
Current smoker 7/37 (18.9) 1/17 (5.9) 3.73 (p=0.21)
Tap water source
Municipal water 32/35 (91.4) 10/16 (62.5) 17.78 (p=0.02)**
Private well 3/35 (8.6) 6/16 (37.5) referent
Tap water exposure
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Cases (N=37) Controls (N=17)
Demographic characteristic or
exposure
n (%) n (%) Unadjusted odds
ratio (p-value)*
Used tap water to rinse lens case 23/37 (62.2) 12/17 (70.6) 0.68 (p=0.39)
Used tap water to clean lens case 18/37 (48.7) 12/17 (70.6) 0.39 (p=0.11)
Used tap water to rinse lenses 17/37 (46.0) 5/17 (29.4) 2.04 (p=0.20)
Ever used tap water to store
lenses
18/36 (50.0) 1/17 (5.9) 16.00 (p=0.001)**
Lens hygiene
Ever topped off solution in lens
case
24/36 (66.7) 5/17 (29.4) 4.80 (p=0.01)**
Always washed hands before
inserting lenses
21/36 (58.3) 11/17 (64.7) 0.76 (p=0.77)
Recreational water
Any hot tub use while wearing
lenses in previous month
2/37 (5.4) 2/17 (11.8) 0.43 (p=0.37)
Any swimming while wearing
lenses in previous month
3/37 (8.1) 1/17 (5.9) 1.41 (p=0.63)
Showering
Ever showered while wearing
lenses
17/37 (46.0) 10/17 (58.8) 0.60 (p=0.28)
Ever washed their face while
wearing lenses
31/36 (86.1) 13/17 (76.5) 1.91 (p=0.31)
*
Because of the small numbers in this analysis, exact p-values were calculated using Fisher’s test in place of confidence intervals
**
Significant at 95% confidence level. If OR was undefined, no controls had this exposure, thus the OR ((number of exposed cases/number of 
unexposed cases)/(number of exposed controls/number of unexposed controls) could not be calculated because division by zero is undefined.
†
Includes 8 orthokeratology patients and 1 patient who reported used a contact for therapeutic reasons. This patient did report sleeping in their 
lenses every night, but no additional data was available to explain the therapeutic lens wear for this patient.
††
Includes patients who wore lenses for orthokeratology and therapeutic reasons
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Table 3
Prevalence and odds ratio of demographic characteristics and potential risk factors for 
infection in Acanthamoeba keratitis cases and controls who wore rigid gas-permeable 












exposure n (%) n (%)
Unadjusted
odds ratio (p-
value)* n (%) n (%)
Age
25 years or younger 2/28 (7.1) 0 undefined
(p=0.23)
4/9 (44.4) 0
26–55 years 6/28 (21.4) 8/16 (50.0) referent 2/9 (22.2) 0
56 years or older 20/28 (71.4) 8/16 (50.0) 3.3 (p=0. 07) 3/9 (33.3) 0
Duration of daily
lens wear
<12 hrs./day 12/28 (42.9) 4/17 (23.5) 2.8 (p=0.12) 6/9 (66.7) 0
>12-16 hrs./day 14/28 (50.0) 13/17
(76.5)
referent 2/9 (22.2) 0









referent 2/9 (22.2) 0
Slept with lenses in
some nights
5/27 (18.5) 1/17 (5.9) 3.6 (p=0.24) 1/9 (11.1) 0
Slept with lenses in
every night
0 0 6/9 (66.7) 0
Tap water source
Municipal water 25/27 (92.6) 10/16
(62.5)
7.5 (p=0.02)** 6/8 (87.5) 0
Private well 2/27 (7.4) 6/16 (37.5) referent 1/8 (12.5) 0
Tap water exposure
Ever used tap water
to store lenses





solution in lens case
18/27 (66.7) 5/17 (29.4) 4.8 (p=0.02)** 7/9 (77.8) 0
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